This HTML5 document contains 53 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n16http://linked.opendata.cz/resource/drugbank/drug/DB04734/identifier/pubchem-substance/
n10http://linked.opendata.cz/resource/mesh/concept/
n14http://linked.opendata.cz/resource/drugbank/drug/DB04734/identifier/drugbank/
n7http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n17http://linked.opendata.cz/resource/drugbank/drug/DB04734/identifier/chebi/
n8http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n9http://linked.opendata.cz/ontology/mesh/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n15http://linked.opendata.cz/resource/drugbank/drug/DB04734/identifier/kegg-compound/
n12http://linked.opendata.cz/resource/drugbank/drug/DB04734/identifier/pdb/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04734/identifier/pubchem-compound/

Statements

Subject Item
n2:DB04734
rdf:type
n3:Drug
n3:description
Citraconic acid is one of the isomeric dicarboxylic acids produced by the distillation of citric acid, or as metabolites by microorganisms, cis-CH3-C(CO2H)=CHCO2H; the trans-isomer is mesaconic acid.
n3:group
experimental
owl:sameAs
n7:DB04734 n8:DB04734
dcterms:title
Citraconic acid
adms:identifier
n12:MEZ n13:643798 n14:DB04734 n15:C02226 n16:46505839 n17:30719
n3:synonym
trans-2-Methyl-2-butenedioic acid 2-methylfumarate (2E)-2-METHYLBUT-2-ENEDIOIC ACID METHYLMALEIC ACID Kyselina mesakonova cis-Methylbutenedioic acid Citraconate 2-Methylfumaric acid mesaconic acid mesaconate Methylfumaric acid
n3:synthesisReference
Chiyuki Fujii, Yoshio Kosai, Iwao Kibayashi, "Method for preparation of citraconic acid and derivatives thereof." U.S. Patent US3931241, issued November, 1973.
n9:hasConcept
n10:M0198359
n3:IUPAC-Name
n4:271B4E3D-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4E43-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4E42-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4E3F-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4E40-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4E41-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4E52-363D-11E5-9242-09173F13E4C5 n4:271B4E3B-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4E39-363D-11E5-9242-09173F13E4C5 n4:271B4E3C-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4E3A-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4E49-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4E4A-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4E44-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4E45-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4E47-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4E46-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4E48-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
498-23-7
n3:Bioavailability
n4:271B4E4E-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4E50-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4E51-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B4E53-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4E4D-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4E4C-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4E4F-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4E3E-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4E4B-363D-11E5-9242-09173F13E4C5